GEldridge

TL3 Regular · Málaga, ES

Clinician. Posts general information only, and says so every time.

Joined 15 September 2024 · last posted 3d · groups: clinicians

133 posts, newest first. Showing up to 150.

Prescription portability between countries Replied, post #112 · Access › International · 25 Jul 2026 · 0 likes Confirming post #111 from a second method, which matters more than confirming it from a second person. Regional practice around what a pharmacy will and will not do…
How to ask a question when you cannot say why you are asking it Replied, post #51 · Start Here › How to Ask · 25 Jul 2026 · 0 likes Post #47 describes the usual case. This is about the unusual one. When you quote a figure from somewhere else, say where from. Not as a formality — the answer…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #66 · Access › Insurance & coverage · 25 Jul 2026 · 15 likes The single most useful preparation is obtaining the actual criteria document rather than working from what somebody was told on the phone.
What steady state means for the decision to escalate Replied, post #32 · Practice › Dosing & titration · 20 Jul 2026 · 27 likes Before the thread moves on from steady state — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
Why the Start Here categories exist, and what they are not for Replied, post #12 · Start Here › Welcome · 19 Jul 2026 · 0 likes If someone has run Start properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #72 · Practice › Administration · 17 Jul 2026 · 5 likes Practical experience of completing a dose, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Substitution between formats during a shortage — what changed since Replied, post #18 · Access › Shortages · 17 Jul 2026 · 15 likes I read post #14 twice before replying, because I had assumed the opposite. Shortage predictions: regulators and suppliers issue shortage alerts before they become…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #72 · Practice › Dosing & titration · 17 Jul 2026 · 24 likes Titrating on symptoms rather than on the calendar is what most people here actually do. It is defensible, it is not what was studied, and describing it as the protocol…
CJC-1295 with and without DAC: what the modification does Replied, post #111 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 0 likes I have been on both sides of the CJC-1295 argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #43 · Practice › Dosing & titration · 6 Jul 2026 · 8 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
Journal club: what we got wrong in an earlier session Replied, post #55 · Evidence › Journal club · 5 Jul 2026 · 12 likes Coming back to post #51, because the follow-up matters more than the original answer. The most common failure mode is spending fifty minutes on the effect size and ten…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #11 · Start Here › Welcome · 4 Jul 2026 · 10 likes Having read the whole Reading order thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #68 · Wellbeing › Sleep · 25 Jun 2026 · 0 likes Answering the question post #66 raises rather than the one it answers. Consistency of timing does more for most people's sleep than any intervention discussed in this…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #10 · Analytics › Home & field testing · 22 Jun 2026 · 0 likes The strongest argument against my own position on Cost versus information, stated as well as I can state it, since nobody else has yet.
Lipid changes during rapid weight loss: the expected trajectory Replied, post #6 · Clinical › Bloodwork · 20 Jun 2026 · 0 likes That reframing is the whole thing. The facts I already had.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #12 · Analytics › Home & field testing · 19 Jun 2026 · 29 likes Where I part company with post #8, and it is a narrow parting. Two questions I would want answered before drawing anything from the consumer-accessible tests data…
Journal club: what we got wrong in an earlier session Replied, post #11 · Evidence › Journal club · 18 Jun 2026 · 19 likes Post #7 describes the usual case. This is about the unusual one. Bringing the previous paper on the same question makes the session much better and doubles the…
Compounds this community declines to help with, and why — does this still hold? Replied, post #2 · Compounds › Other compounds · 14 Jun 2026 · 28 likes The opening post describes the usual case. This is about the unusual one. Dose conversions between related compounds in this subcategory are made far too casually.…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #22 · Documentation › Doc review · 13 Jun 2026 · 19 likes Counterpoint on draft on reconstitution arithmetic, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #71 · Safety › Contraindications · 12 Jun 2026 · 6 likes No notes. Posting so the count is not one.
Reading a home test result without over-claiming Replied, post #70 · Analytics › Home & field testing · 7 Jun 2026 · 29 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #43 · Practice › Administration · 20 May 2026 · 0 likes The failure mode on completing a dose is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #104 · Research Methods › Statistics · 14 May 2026 · 19 likes Adding thanks rather than a view. I do not have a view worth the space.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #75 · Outcomes › Body composition · 13 May 2026 · 1 like Where I part company with post #74, and it is a narrow parting. I have no financial interest in anything named in this thread and I want to say so before I comment on…
The most useful thing you learned here that was not the answer you came for Replied, post #41 · Lounge › Off topic · 10 May 2026 · 0 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. I have seen it go…
Prescription requirements and telehealth models — a second dataset Replied, post #17 · Sourcing › Regulatory · 2 May 2026 · 28 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence. I have said this before in…
Amylin receptor signalling and satiety — what changed since Replied, post #71 · Pharmacology › Receptor biology · 30 Apr 2026 · 6 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #125 · Analytics › Mass spectrometry · 29 Apr 2026 · 2 likes Resolution: "high resolution" commonly means I have kept the units in throughout, for the obvious reason.
What a certificate commits its issuer to — one year on Replied, post #58 · Analytics › COA interpretation · 29 Apr 2026 · 28 likes The fields that make one usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the result as a number, and the…
The best-written scientific paper you have read Replied, post #20 · Lounge › Off topic · 27 Apr 2026 · 2 likes I have no financial interest in anything named in this thread and I want to say so before I comment on best-written scientific paper, because it is the sort of subject…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #118 · Analytics › Mass spectrometry · 27 Apr 2026 · 2 likes Answering the question post #116 raises rather than the one it answers. I have three months of notes on Charge states and the honest summary is that the trend is real…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #96 · Practice › Reconstitution · 24 Apr 2026 · 0 likes Post #92 describes the usual case. This is about the unusual one. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
[2026 update] Waist circumference technique and its repeatability Replied, post #5 · Outcomes › Progress reports · 22 Apr 2026 · 14 likes Narrowing post #4, because the general version has more than one answer. Summarising the Waist circumference technique thread so far, since it is long and the answer is…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #39 · Sourcing › Independent verification · 15 Apr 2026 · 0 likes I would put moderate confidence on the mainstream reading of Janoshik and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #9 · Practice › Administration · 14 Apr 2026 · 20 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
Foaming during reconstitution and whether it matters — the long version Replied, post #96 · Practice › Reconstitution · 12 Apr 2026 · 29 likes Post #94 and I disagree about the size of the effect, not about the direction. Trying to state the Foaming during reconstitution position in a way that someone who…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Started this topic · Evidence › Journal club · 7 Apr 2026 · 3 likes Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Working notes on STEP 1…
[2026 update] Thyroid function tests during substantial weight change Replied, post #20 · Clinical › Bloodwork · 22 Mar 2026 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. Where I would push back on the Thyroid function tests during substantial consensus is the…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #82 · Lounge › Introductions · 16 Mar 2026 · 7 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here. I would rather…
Five questions in one post gets you one answer — how to split them Replied, post #27 · Start Here › How to Ask · 8 Mar 2026 · 17 likes Taking post #24 at face value and following it one step further. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method.…
Absence of evidence and evidence of absence Replied, post #20 · Research Methods › Statistics · 4 Mar 2026 · 16 likes Taking absence of evidence seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
Foaming during reconstitution and whether it matters — the long version Replied, post #52 · Practice › Reconstitution · 4 Mar 2026 · 16 likes Saving this. It is the version I will quote when the question comes round again.
Why a compound being unapproved is not the same as being illegal to possess Replied, post #63 · Sourcing › Regulatory · 27 Feb 2026 · 23 likes Worth separating two things that post #61 runs together. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #53 · Pharmacology › Pharmacokinetics · 25 Feb 2026 · 1 like Speaking only to Washout as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #3 · Practice › Interactions · 24 Feb 2026 · 14 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 13 Feb 2026 · 33 likes The opening post describes the usual case. This is about the unusual one. Nausea appears in the amylin-analogue literature as it does in the incretin literature, and…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #73 · Documentation › Wiki requests · 5 Feb 2026 · 6 likes Requests for a page summarising a supplier are declined, because that is what the vendor documentation set is for and it has its own standards. Filing this under things…
Trifluoroacetate content and its consequences Replied, post #68 · Analytics › Impurities & related substances · 2 Feb 2026 · 0 likes Counterpoint on trifluoroacetate content, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull…
Trifluoroacetate content and its consequences Replied, post #15 · Analytics › Impurities & related substances · 24 Jan 2026 · 32 likes I have been on both sides of the trifluoroacetate content argument in this category within eighteen months, which should tell you how strong the evidence for either…
Anaesthesia and elective surgery: the aspiration question Replied, post #2 · Practice › Interactions · 18 Jan 2026 · 27 likes On the opening post — agreed on the reasoning, with one qualification. A pharmacist can answer most questions in this subcategory in a few minutes with access to a…
Coming back to: Training through a dose escalation week Replied, post #6 · Nutrition & Training › Resistance training · 10 Jan 2026 · 23 likes Everything in post #4 holds. The case it does not cover is the one I have. Protein and training are complements rather than alternatives, and the published work on…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #85 · Compounds › Semaglutide · 4 Jan 2026 · 24 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #115 · Documentation › Doc review · 19 Dec 2025 · 32 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. That is all the detail I have.…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #15 · Pharmacology › Receptor biology · 16 Dec 2025 · 5 likes Coming back to post #13, because the follow-up matters more than the original answer. Receptor desensitisation and internalisation are real phenomena in vitro and their…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #8 · Sourcing › Logistics · 15 Dec 2025 · 15 likes Post #6 put the caveat in the right place and I want to underline it. Peak periods and public holidays affect this more than any other factor and are entirely…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #36 · Access › Pricing · 13 Dec 2025 · 21 likes One more thing on Price changes that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
Publication bias detection and its low power — does this still hold? Replied, post #2 · Evidence › Meta-analyses · 10 Dec 2025 · 0 likes Posting my Publication bias detection numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted…
Publishing an inconvenient result: a case study — the long version Replied, post #65 · Sourcing › Independent verification · 10 Dec 2025 · 12 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Batch date after test date, and other internal inconsistencies Replied, post #24 · Analytics › COA interpretation · 6 Dec 2025 · 2 likes This follows post #23 rather than contradicting it. What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated…
Pooling trials with different estimands — what changed since Replied, post #60 · Evidence › Meta-analyses · 3 Dec 2025 · 0 likes Worth separating Pooling trials with different estimands as a question about the compound from Pooling trials with different estimands as a question about the…
Where the integrator drew the baseline, and how much it moved the number Replied, post #22 · Analytics › HPLC & UHPLC · 24 Nov 2025 · 0 likes Confirming post #20 from a second method, which matters more than confirming it from a second person. An honest declaration on integrator: I have a prior here and it is…
Coming back to: Pen dose counters: what a click does and does not guarantee Started this topic · Devices › Pens & autoinjectors · 21 Nov 2025 · 0 likes Pen dose counters: what a click does and does not guarantee — setting out what I have, and where I think it stops being reliable. Reading back through what has been…
Pen dose counters: what a click does and does not guarantee Replied, post #14 · Devices › Pens & autoinjectors · 13 Nov 2025 · 2 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
[2026 update] What steady state means for the decision to escalate Replied, post #37 · Practice › Dosing & titration · 8 Nov 2025 · 13 likes The honest answer on steady state is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
Titles that describe the question, not the situation Replied, post #134 · Start Here › How to Ask · 29 Oct 2025 · 5 likes Narrowing post #133, because the general version has more than one answer. Quantities without units are the single commonest reason a question sits unanswered. "Two and…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #108 · Compounds › Tirzepatide · 24 Oct 2025 · 30 likes Two people in this thread mean different things by SURMOUNT-4 and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #148 · Practice › Reconstitution · 19 Oct 2025 · 0 likes I had written a reply contradicting post #145 and deleted it. Here is what survived. Practical note on 10 mg vial reconstituted three: write down what you expect before…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #40 · Start Here › Welcome · 16 Oct 2025 · 0 likes That reframing is the whole thing. The facts I already had.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #72 · Documentation › Doc review · 10 Oct 2025 · 0 likes The strongest argument against my own position on Promotion criteria, stated as well as I can state it, since nobody else has yet.
The nausea timeline across the first four weeks, with a tabulated log Replied, post #132 · Practice › Side effects · 8 Oct 2025 · 14 likes Taking nausea timeline seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #42 · Compounds › Oral incretins · 25 Sep 2025 · 5 likes The thirty-minute wait before eating is not conservatism. Food in the stomach materially reduces absorption of the oral product, and the instruction exists because the…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #8 · Evidence › Study critique · 12 Sep 2025 · 0 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.…
Why the timeline is on the right and not the left Replied, post #63 · Meta › Site feedback · 3 Sep 2025 · 31 likes What I would tell a new member reading about timeline for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #35 · Practice › Dosing & titration · 2 Sep 2025 · 18 likes Coming back to post #33, because the follow-up matters more than the original answer. Escalating before steady state means you are judging a dose you have not yet fully…
A parcel that arrived warm: a decision process, not a verdict Replied, post #21 · Practice › Storage & stability · 1 Sep 2025 · 0 likes Post #18 put the caveat in the right place and I want to underline it. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #99 · Data & Tools › Calculators · 30 Aug 2025 · 1 like I think the titration planner refuses question is answerable and has not been answered, which is a more optimistic position than most of this thread.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #110 · Evidence › Journal club · 25 Aug 2025 · 3 likes The arithmetic in post #109 is right; the assumption feeding it is the part to check. The most common failure mode is spending fifty minutes on the effect size and ten…
Cross-border purchase rules within the EU Replied, post #4 · Regional › European Union · 24 Aug 2025 · 5 likes Nobody has said the unglamorous part of cross-border purchase rules within yet, so: most of the variation is explained by things that are boring to write about and easy…
Enforcement priorities versus written rules — does this still hold? Replied, post #19 · Sourcing › Regulatory · 20 Aug 2025 · 0 likes What I would check first on Enforcement priorities is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Are there stupid questions here? A staff answer, at length Replied, post #66 · Start Here › Welcome · 12 Aug 2025 · 14 likes The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #96 · Compounds › Repair & healing peptides · 9 Aug 2025 · 19 likes Coming back to post #92, because the follow-up matters more than the original answer. I would keep TB-500 and thymosin beta-4 and the decision it usually gets used for…
A request that was declined, and the reasoning — a second dataset Replied, post #28 · Documentation › Wiki requests · 8 Aug 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
A ten-fold dose error caught before injection — one year on Replied, post #60 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #152 · Compounds › Tirzepatide · 1 Aug 2025 · 0 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
Sequence verification for an obscure compound: how it is done Replied, post #108 · Compounds › Other compounds · 29 Jul 2025 · 3 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Coming back to: Official shortage notices and what they authorise Replied, post #62 · Access › Shortages · 19 Jul 2025 · 0 likes Confirming post #61 from a second method, which matters more than confirming it from a second person. Shortage-driven price movement is real and is a separate question…
Reflectance and photometric devices: precision in practice Replied, post #2 · marked as the solution · Analytics › Home & field testing · 12 Jul 2025 · 7 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
Publishing an inconvenient result: a case study Replied, post #48 · Sourcing › Independent verification · 12 Jul 2025 · 0 likes Post #44 put the caveat in the right place and I want to underline it. Trying to state the publishing an inconvenient result position in a way that someone who…
Counter-ion content and its effect on measured mass Replied, post #85 · Analytics › Mass spectrometry · 7 Jul 2025 · 3 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
Discussing something you have already been doing — the long version Replied, post #5 · Clinical › Prescriber conversations · 6 Jul 2025 · 31 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. The strength of my opinion here…
Sodium, potassium and magnesium when intake drops Replied, post #44 · Nutrition & Training › Hydration & electrolytes · 5 Jul 2025 · 0 likes I read post #40 twice before replying, because I had assumed the opposite. Commercial rehydration formulations are designed for a specific purpose and are not…
Which panel is worth repeating and which is worth ignoring Replied, post #53 · Clinical › Bloodwork · 5 Jul 2025 · 5 likes Panel would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
[2026 update] Clearance pathways and what renal impairment changes Replied, post #66 · Pharmacology › Pharmacokinetics · 26 Jun 2025 · 7 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #57 · Clinical › Comorbidities · 22 Jun 2025 · 0 likes Coming back to post #53, because the follow-up matters more than the original answer. Before the thread moves on from Cardiovascular risk — what is the sample size…
Coming back to: When "no data" is the complete and final answer Replied, post #15 · Compounds › Other compounds · 16 Jun 2025 · 0 likes Adding the measurement that post #14 says would settle it. Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to…
A report I filed that turned out to be wrong, and the correction Replied, post #84 · Sourcing › Vendor reports · 3 Jun 2025 · 30 likes Building on post #83 rather than restating it. Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #74 · Practice › Reconstitution · 20 May 2025 · 26 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
Reading a trial's population section before its results — does this still hold? Replied, post #116 · Evidence › Trials · 18 May 2025 · 18 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
Pregnancy as an absolute contraindication Replied, post #24 · Safety › Contraindications · 17 May 2025 · 0 likes Where a condition appears as a warning rather than a contraindication, the decision is a clinical one rather than a prohibition.
Coverage for the indication versus for the drug Replied, post #46 · Access › Insurance & coverage · 29 Apr 2025 · 25 likes Summarising the coverage thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
Shakes versus food: a pragmatic assessment — the long version Replied, post #5 · Nutrition & Training › Protein & intake · 20 Apr 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #83 · Practice › Reconstitution · 19 Apr 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Retatrutide dose escalation in the published trials Replied, post #62 · Compounds › Retatrutide · 29 Mar 2025 · 7 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
Coming back to: What published stability data actually covers, and what it does not Replied, post #12 · Practice › Storage & stability · 28 Mar 2025 · 0 likes I would put moderate confidence on the mainstream reading of published stability data actually covers and no more. That is not scepticism for its own sake; it is where…
Preparing for an appointment: one page, three questions Replied, post #12 · Clinical › Prescriber conversations · 24 Mar 2025 · 2 likes Write the questions down in advance and put the most important one first. Appointments end and the order is what decides which questions get answered.
Triple agonism: additive, synergistic, or neither? Replied, post #28 · Compounds › Retatrutide · 19 Mar 2025 · 5 likes The most useful thing anyone has posted about triple agonism in this category was a table of what had been measured and by whom. That is what I would want again.
Coverage for the indication versus for the drug Replied, post #5 · Access › Insurance & coverage · 19 Mar 2025 · 17 likes Coverage sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #134 · Sourcing › Vendor reports · 19 Mar 2025 · 9 likes Recording a reorder result against the original is one of the highest-value contributions here, because consistency over time is what a single result cannot show.
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #50 · Evidence › Journal club · 17 Mar 2025 · 0 likes Coming back to post #46, because the follow-up matters more than the original answer. Counterpoint on SURMOUNT-OSA, offered without confidence: the same observation is…
A ten-fold dose error caught before injection Replied, post #8 · Devices › Syringes & needles · 11 Mar 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
Review: a draft on reconstitution arithmetic, with objections Replied, post #49 · Documentation › Doc review · 8 Mar 2025 · 6 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. The mechanism is plausible, which is…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #92 · Sourcing › Regulatory · 3 Mar 2025 · 2 likes Genuine question rather than a rhetorical one: has anyone here actually observed pharmaceutical compounding rules, as opposed to read about it? The thread is long and I…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #71 · Sourcing › Regulatory · 2 Mar 2025 · 26 likes Post #70 is the version of this I will quote in future. One addition. Something worth flagging about pharmaceutical compounding rules: the strongest-sounding claims in…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #118 · Evidence › Journal club · 6 Feb 2025 · 3 likes Narrowing post #117, because the general version has more than one answer. Small methodological point on SURPASS-2: repeating a measurement is cheap and resolves most…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #12 · Evidence › Meta-analyses · 27 Jan 2025 · 27 likes Building on post #11 rather than restating it. Quality assessment of included trials should change the analysis rather than sit beside it. A sensitivity analysis…
Why mass spectrometry cannot tell you about an epimer Replied, post #28 · Analytics › Mass spectrometry · 15 Jan 2025 · 0 likes Post #25 is right about the mechanism and I think understates the practical bit. Offering a way to settle mass spectrometry rather than another opinion about it. Two…
What we do not know about retatrutide, listed explicitly Replied, post #51 · Compounds › Retatrutide · 10 Jan 2025 · 29 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
When "no data" is the complete and final answer Replied, post #59 · Compounds › Other compounds · 6 Jan 2025 · 27 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
[2026 update] New subcategory: rationale and scope Replied, post #115 · Meta › Announcements · 2 Jan 2025 · 7 likes Coming back to post #112, because the follow-up matters more than the original answer. Notifications: watching this subcategory means you receive notifications when…
[2026 update] New subcategory: rationale and scope Replied, post #65 · Meta › Announcements · 14 Dec 2024 · 12 likes Everything in post #63 holds. The case it does not cover is the one I have. Thank you for announcing it in advance rather than after. The number of places that do the…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #39 · Practice › Reconstitution · 7 Dec 2024 · 10 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #57 · Compounds › Semaglutide · 3 Dec 2024 · 18 likes On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower escalation was not studied. That means the evidence supports not…
EMA product information as a primary source — does this still hold? Replied, post #138 · Regional › European Union · 18 Nov 2024 · 1 like Taking EMA product information seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #73 · Clinical › Prescriber conversations · 18 Nov 2024 · 2 likes Everything in post #71 holds. The case it does not cover is the one I have. Nothing here is medical advice, and this subcategory exists to help people ask better…
Requesting a page: what makes a good request — what changed since Replied, post #106 · Documentation › Wiki requests · 12 Oct 2024 · 33 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #88 · Access › Shortages · 12 Oct 2024 · 19 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
Blind submission and why it changes minds Replied, post #84 · Sourcing › Independent verification · 10 Oct 2024 · 17 likes Confirming post #81 from a second method, which matters more than confirming it from a second person. Distinguishing three things in the blind submission discussion…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #84 · Sourcing › Independent verification · 25 Sep 2024 · 22 likes Understood. Thank you for being specific about the limits of it.
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #7 · Compounds › Other compounds · 18 Sep 2024 · 7 likes Reading rather than answering, but this is the post I would point somebody at.
Why a preprint's supplementary material is often the best part Replied, post #12 · Evidence › Preprints · 4 Sep 2024 · 7 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #31 · Compounds › Oral incretins · 1 Sep 2024 · 1 like I had written a reply contradicting post #30 and deleted it. Here is what survived. What I want from this orforglipron thread is the list of things that would need to…
The topic list is dense — is that deliberate? Replied, post #15 · Meta › Site feedback · 17 Aug 2024 · 1 like Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
Guidelines revision: what changed and why Replied, post #16 · Meta › Announcements · 25 Jul 2024 · 18 likes A definition problem is doing most of the work in this guidelines revision discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what…